(Q37892758)

24 August 2017

1 reference

title

Gut-liver interaction in triglyceride-rich lipoprotein metabolism (English)

1 reference

24 August 2017

1 reference

1 reference

1

Changting Xiao

1 reference

24 August 2017

Joanne Hsieh

2

1 reference

24 August 2017

Khosrow Adeli

series ordinal

3

1 reference

24 August 2017

Gary F Lewis

series ordinal

4

1 reference

24 August 2017

publication date

21 June 2011

1 reference

American Journal of Physiology - Endocrinology and Metabolism

24 August 2017

published in

1 reference

24 August 2017

volume

301

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

E429-46

1 reference

Intestinal lipoprotein overproduction in insulin-resistant states

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Overproduction of large VLDL particles is driven by increased liver fat content in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Coordinated regulation of the metabolome and lipidome at the host-microbial interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

New insights into the fatty acid-binding protein (FABP) family in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Preferential uptake of dietary Fatty acids in adipose tissue and muscle in the postprandial period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The level and compartmentalization of phosphatidate phosphatase-1 (lipin-1) control the assembly and secretion of hepatic VLDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Selective versus total insulin resistance: a pathogenic paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

A predominant role of acyl-CoA:monoacylglycerol acyltransferase-2 in dietary fat absorption implicated by tissue distribution, subcellular localization, and up-regulation by high fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) stimulates VLDL assembly through activation of cell death-inducing DFFA-like effector B (CideB)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Identification of acyl coenzyme A:monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Insulin signaling meets mitochondria in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Intestinal cholecystokinin controls glucose production through a neuronal network

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Chronic administration of the glucagon-like peptide-1 analog, liraglutide, delays the onset of diabetes and lowers triglycerides in UCD-T2DM rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Triacylglycerol hydrolase: role in intracellular lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The cloning and expression of a murine triacylglycerol hydrolase cDNA and the structure of its corresponding gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related ki

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The AAA-ATPase p97 facilitates degradation of apolipoprotein B by the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Chitosan supplementation and fat absorption in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Intestinal metabolism of plasma free fatty acids. Intracellular compartmentation and mechanisms of control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Changes in lipoprotein kinetics during therapy with fenofibrate and other fibric acid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Insulin resistance and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Regulation of plasma triglycerides in insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation of the liver X receptor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-contain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Selective partitioning of dietary fatty acids into the VLDL TG pool in the early postprandial period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Dietary fatty acids make a rapid and substantial contribution to VLDL-triacylglycerol in the fed state

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

A combination of HNF-4 and Foxo1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

A proposed model for the assembly of chylomicrons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Intestinal lipid absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

An intrinsic gut leptin-melanocortin pathway modulates intestinal microsomal triglyceride transfer protein and lipid absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Common variants at 30 loci contribute to polygenic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Rosiglitazone improves intestinal lipoprotein overproduction in the fat-fed Syrian Golden hamster, an animal model of nutritionally-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Intestinal and hepatic cholesterol carriers in diabetic Psammomys obesus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Hepatic lipase mRNA, protein, and plasma enzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

New insights into the regulation of HDL metabolism and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The glucagon receptor is required for the adaptive metabolic response to fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Incretin-based therapies for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Chylomicron and apoB48 metabolism in the JCR:LA corpulent rat, a model for the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Systemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glycerol and free fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Fasting in healthy subjects is associated with intrahepatic accumulation of lipids as assessed by 1H-magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Lipid-dependent bidirectional traffic of apolipoprotein B in polarized enterocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

CD36 is important for chylomicron formation and secretion and may mediate cholesterol uptake in the proximal intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Plasma resistin levels correlate with determinants of the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Cytoplasmic lipid droplets are sites of convergence of proteasomal and autophagic degradation of apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Diurnal regulation of MTP and plasma triglyceride by CLOCK is mediated by SHP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Hepatic autophagy mediates endoplasmic reticulum stress-induced degradation of misfolded apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Abetalipoproteinemia. New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Intestinal microbiota during infancy and its implications for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Mobilisation of enterocyte fat stores by oral glucose in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Fasted to fed trafficking of Fatty acids in human adipose tissue reveals a novel regulatory step for enhanced fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Mechanisms targeting apolipoprotein B100 to proteasomal degradation: evidence that degradation is initiated by BiP binding at the N terminus and the formation of a p97 complex at the C terminus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The identification of the SNARE complex required for the fusion of VLDL-transport vesicle with hepatic cis-Golgi

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

VLDL exits from the endoplasmic reticulum in a specialized vesicle, the VLDL transport vesicle, in rat primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

COPII proteins are required for Golgi fusion but not for endoplasmic reticulum budding of the pre-chylomicron transport vesicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

PKC zeta-mediated phosphorylation controls budding of the pre-chylomicron transport vesicle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Acute suppression of apo B secretion by insulin occurs independently of MTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Interleukin-6 mediates hepatic hypersecretion of apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

FoxO1 and hepatic lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The effects of prolonged fasting on plasma triglyceride kinetics in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Diabetic dyslipidaemia: from basic research to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Increased dietary substrate delivery alters hepatic fatty acid recycling in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The intestine as a regulator of cholesterol homeostasis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Formation and transport of chylomicrons by enterocytes to the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

The role of the LDL receptor in apolipoprotein B secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Adiponectin and lipoprotein particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Proteomic profiling of intestinal prechylomicron transport vesicle (PCTV)-associated proteins in an animal model of insulin resistance (94 char).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Effects of acute hyperglucagonemia on hepatic and intestinal lipoprotein production and clearance in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Regulation of microsomal triglyceride transfer protein by apolipoprotein A-IV in newborn swine intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

Liver Fatty Acid-binding Protein Initiates Budding of Pre-chylomicron Transport Vesicles from Intestinal Endoplasmic Reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00178.2011

10.1152/AJPENDO.00178.2011

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference